These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 16613527)

  • 1. Treatment and pharmacologic management of BPH in the context of common comorbidities.
    O'Leary MP
    Am J Manag Care; 2006 Apr; 12(5 Suppl):S129-40. PubMed ID: 16613527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BPH: epidemiology and comorbidities.
    McVary KT
    Am J Manag Care; 2006 Apr; 12(5 Suppl):S122-8. PubMed ID: 16613526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BPH: costs and treatment outcomes.
    Nickel JC
    Am J Manag Care; 2006 Apr; 12(5 Suppl):S141-8. PubMed ID: 16613528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.
    Lowe FC
    BJU Int; 2005 Jun; 95 Suppl 4():12-8. PubMed ID: 15871731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A current review of medical therapy for benign prostatic hyperplasia.
    Brown GA; Sussman DO
    J Am Osteopath Assoc; 2004 Feb; 104(2 Suppl 2):S11-6. PubMed ID: 15038398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.
    Seftel A; Rosen R; Kuritzky L
    Int J Impot Res; 2007; 19(4):386-92. PubMed ID: 17377613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transurethral resection of the prostate: failure patterns and surgical outcomes in patients with symptoms refractory to alpha-antagonists.
    Blanchard K; Hananel A; Rutchik S; Sullivan J
    South Med J; 2000 Dec; 93(12):1192-6. PubMed ID: 11142455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA; McVary KT
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.
    Agha AH; Roy JB; Culkin DJ; Lyon K
    Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
    Naslund MJ; Miner M
    Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current drug therapy of benign prostatic hyperplasia].
    Schmidbauer CP; Madersbacher S
    Wien Med Wochenschr; 1996; 146(8):161-4. PubMed ID: 8767400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia.
    Rosen RC
    Curr Opin Urol; 2006 Jan; 16(1):11-9. PubMed ID: 16385195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign prostatic hyperplasia: drug and nondrug therapies.
    Bruskewitz RC
    Geriatrics; 1992 Dec; 47(12):39-42, 45. PubMed ID: 1280242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment of BPH.
    Roylance P; Gibelin B; Espié J
    Biomed Pharmacother; 1995; 49(7-8):332-8. PubMed ID: 8562858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of benign prostatic hypertrophy.
    Nix JW; Carson CC
    Can J Urol; 2007 Dec; 14 Suppl 1():53-7. PubMed ID: 18163946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benign prostatic hyperplasia: medical therapy].
    Schlenker B; Gratzke C; Weidlich P; Seitz M; Reich O; Stief CG
    MMW Fortschr Med; 2007 Aug; 149(33-34):29-31; quiz 32. PubMed ID: 17912863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?
    Carson CC
    BJU Int; 2006 Apr; 97 Suppl 2():39-43; discussion 44-5. PubMed ID: 16507053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.